T Cell-Mediated Transport of Polymer Nanoparticles across the Blood-Brain Barrier

Delivery of therapeutics to the central nervous system (CNS) is challenging due to the presence of the blood-brain barrier (BBB). Amongst various approaches that have been explored to facilitate drug delivery to the CNS, the use of cells that have the intrinsic ability to cross the BBB is relatively unexplored, yet very attractive. This paper presents a first proof-of-concept that demonstrates the feasibility of activated effector/memory CD4(+) helper T cells (CD4(+) T-EM cells) as carriers for the delivery of polymer nanoparticles across the BBB. This study shows that CD4(+) T-EM cells can be decorated with poly(ethylene glycol)-modified polystyrene nanoparticles using thiol-maleimide coupling chemistry, resulting in the immobilization of approximate to 105 nanoparticles per cell as determined by confocal microscopy. The ability of these cells to serve as carriers to transport nanoparticles across the BBB is established in vitro and in vivo. Using in vitro BBB models, CD4(+) T-EM cells are found to be able to transport nanoparticles across the BBB both under static conditions as well as under physiological flow. Finally, upon systemic administration, nanoparticle-modified T cells are shown to enter the brain parenchyma of mice, demonstrating the brain delivery potential of this T cell subset in allogeneic hosts.

Automated summary

This study demonstrates the feasibility of using activated effector/memory CD4(+) helper T cells as carriers for delivering polymer nanoparticles across the blood-brain barrier. In vitro and in vivo experiments confirm the ability of these cells to transport nanoparticles across the barrier, showing the potential for brain delivery in allogeneic hosts.